News and Insights
Easier access to funding and a clear challenge for innovators launched at London Life Sciences Week
November 18, 2026
Innovation leaders received an exclusive first look of a new co-ordinated funding opportunities portal and healthcare challenge, to show how the capital’s Health Innovation Zone is starting to deliver London’s Life Sciences Strategy.
London’s three Health Innovation Networks (HINs) – Health Innovation Network (HIN) South London, Imperial College Health Partners (ICHP) and UCLPartners – brought together leaders from across the academia, industry, local government, regulation and the NHS on Tuesday 17 November to explore how London can move from strategy to scale.
Hosted in partnership with NHS England (London Region), London Councils and the Mayor of London’s office, the event asked a simple question: What will the London Health Innovation Zone (HIZ) actually change?
Dominique Allwood, CEO of ICHP, Chris Laing, CEO of UCLPartners and Rishi Das-Gupta, CEO of HIN South London recognized how London has a remarkable concentration of world-leading universities, NHS organisations, life sciences businesses and diverse communities, yet world-class research does not automatically translate into wider adoption or better outcomes. The challenge is not generating more innovation, but creating the conditions for it to succeed at scale which is where the HIN’s skills and connections are critical.
Panellists Anita Charlesworth, Senior Visiting Fellow, The King’s Fund, Hannah Witty, NHS England (London Region), Howard Dawber, Deputy Mayor for Business and Growth, Ed Middleton, Director of Strategy, MHRA, and Mark Kewley, Director, London Secure Data Environment examined what the strengths of London are, how we can make them better and what needs to happen next.
Two key announcements were:
- The launch of a live curated list of current and upcoming health and care funding opportunities aimed at supporting innovative projects as access to funding is a critical factor for innovations aiming to tackle London’s most pressing health challenges.
- A first look at the Health Innovation Zone Problem Book, which signals to the market where London wants to innovate and invest. It will help focus London’s health and care system and its resources towards innovative solutions; and encourage coordinated pan-London innovation at scale and pace. This work will start with one of London’s biggest priorities, heart health, in partnership with Million Hearts and Minds.
There was also an update about the London Region I (LR1) sandbox, run by the Medicines and Healthcare Products Regulatory Agency (MHRA) in collaboration with NHS England (London region) and the London HINs. The sandbox will enable the staged deployment of innovative technologies in safe, real-world environments. To date, more than 60 device manufacturers have expressed their interest to join the programme across all three London sandbox priority areas, of which we have invited the first three to submit applications and begin the assessment process.
Chris Laing said: “The Health Innovation Zone is a collaboration, not an institution, to show how London is a great city for innovators to start, stay and scale, creating benefits across the capital, the UK and internationally.
“To do this we need to signal back to the market what we need as a health and care system and how we will pay for it. The problem book begins to articulate this, and the funding opportunities webpage shows, in one place, how it could be financed.
“These are important early steps showing how the Health Innovation Zone can work in practice, and the crucial role Health Innovation Networks have in the collaboration.”
For more information please email england.hizlondon@nhs.net